These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35784212)

  • 1. A Chess and Card Room-Induced COVID-19 Outbreak and Its Agent-Based Simulation in Yangzhou, China.
    Shen S; Li W; Wei H; Zhao L; Ye R; Ma K; Xiao P; Jia N; Zhou J; Cui X; Gong J; Cao W
    Front Public Health; 2022; 10():915716. PubMed ID: 35784212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological Characteristics of COVID-19 Outbreak in Yangzhou, China, 2021.
    Zhang YD; Chen D; Hu L; Shen L; Wu RY; Cao FM; Xu JQ; Wang L
    Front Microbiol; 2022; 13():865963. PubMed ID: 35602046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of COVID-19 transmission control in Wenzhou using a modified SEIR model.
    Li W; Gong J; Zhou J; Zhang L; Wang D; Li J; Shi C; Fan H
    Epidemiol Infect; 2021 Jan; 149():e2. PubMed ID: 33413715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Optimal Nucleic Acid Testing Strategy for COVID-19 during the Spring Festival Travel Rush in Mainland China: A Modelling Study.
    Zhou YH; Ma K; Xiao P; Ye RZ; Zhao L; Cui XM; Cao WC
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33673163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling the pulse population-wide nucleic acid screening in mitigating and stopping COVID-19 outbreaks in China.
    Li Q; Bai Y; Tang B
    BMC Infect Dis; 2023 May; 23(1):280. PubMed ID: 37138230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of phase-adjusted interventions for COVID-19 using an improved SEIR model.
    Jiang H; Gu Z; Liu H; Huang J; Wang Z; Xiong Y; Tong Y; Yin J; Jiang F; Chen Y; Jiang Q; Zhou Y
    Epidemiol Infect; 2023 Nov; 152():e9. PubMed ID: 37953743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the complete spatiotemporal spread of the COVID-19 epidemic in mainland China.
    Hu B; Ning P; Qiu J; Tao V; Devlin AT; Chen H; Wang J; Lin H
    Int J Infect Dis; 2021 Sep; 110():247-257. PubMed ID: 33862212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative assessment of the effects of massive nucleic acid testing in controlling a COVID-19 outbreak.
    Zhu W; Zhu Y; Wen Z; Zheng B; Xu A; Yao Y; Wang W
    BMC Infect Dis; 2022 Nov; 22(1):845. PubMed ID: 36371145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission Characteristics and Predictive Model for Recent Epidemic Waves of COVID-19 Associated With OMICRON Variant in Major Cities in China.
    Zheng Y; Wang Y
    Int J Public Health; 2022; 67():1605177. PubMed ID: 36405530
    [No Abstract]   [Full Text] [Related]  

  • 10. Application of genetic algorithm combined with improved SEIR model in predicting the epidemic trend of COVID-19, China.
    Qiu Z; Sun Y; He X; Wei J; Zhou R; Bai J; Du S
    Sci Rep; 2022 May; 12(1):8910. PubMed ID: 35618751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemic spread simulation in an area with a high-density crowd using a SEIR-based model.
    Zhou J; Dong S; Ma C; Wu Y; Qiu X
    PLoS One; 2021; 16(6):e0253220. PubMed ID: 34138911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of the COVID-19 epidemic trends based on SEIR and AI models.
    Feng S; Feng Z; Ling C; Chang C; Feng Z
    PLoS One; 2021; 16(1):e0245101. PubMed ID: 33417605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model-Based Evaluation of Transmissibility and Intervention Measures for a COVID-19 Outbreak in Xiamen City, China.
    Liu W; Guo Z; Abudunaibi B; Ouyang X; Wang D; Yang T; Deng B; Huang J; Zhao B; Su Y; Su C; Chen T
    Front Public Health; 2022; 10():887146. PubMed ID: 35910883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An SEIR Model with Time-Varying Coefficients for Analyzing the SARS-CoV-2 Epidemic.
    Girardi P; Gaetan C
    Risk Anal; 2023 Jan; 43(1):144-155. PubMed ID: 34799850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Spatial accessibility of fever clinics for multi-tiered prevention and control on COVID-19 in Beijing].
    Zhang JW; Han PE; Yang L
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 53(3):543-548. PubMed ID: 34145858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of prolonged incubation period and centralized quarantine on the COVID-19 outbreak in Shijiazhuang, China: a modeling study.
    Zhu W; Zhang M; Pan J; Yao Y; Wang W
    BMC Med; 2021 Dec; 19(1):308. PubMed ID: 34872559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective prediction of the epidemic trend of COVID-19 in Wuhan at four phases.
    Li M; Guo X; Wang X
    J Med Virol; 2021 Apr; 93(4):2493-2498. PubMed ID: 33415760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmission dynamics and the effects of non-pharmaceutical interventions in the COVID-19 outbreak resurged in Beijing, China: a descriptive and modelling study.
    Cui X; Zhao L; Zhou Y; Lin X; Ye R; Ma K; Jiang JF; Jiang B; Xiong Z; Shi H; Wang J; Jia N; Cao W
    BMJ Open; 2021 Sep; 11(9):e047227. PubMed ID: 34493510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Estimation of COVID-19 incidence in Shanghai under optimized epidemic prevention and control strategies].
    Wang XY; Zhang MD; Zhu WL; Liu ZX; Wang WB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Apr; 44(4):552-560. PubMed ID: 37147825
    [No Abstract]   [Full Text] [Related]  

  • 20. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study.
    Wu JT; Leung K; Leung GM
    Lancet; 2020 Feb; 395(10225):689-697. PubMed ID: 32014114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.